ENvue Medical (FEED) Operating Income (2014 - 2026)

ENvue Medical (FEED) has reported Operating Income for 13 consecutive years, with -$5.5 million the latest figure, recorded in Q2 2026.

• On a quarterly basis, Operating Income fell 37.68% year-over-year to -$5.5 million in Q2 2026; TTM through Jun 2026 was -$26.2 million, a 221.33% decrease from a year earlier, with the FY2025 full-year figure at -$22.9 million, down 539.0% from the prior year.
• Operating Income was -$5.5 million for Q2 2026 at ENvue Medical, down from -$3.7 million in the prior quarter.
• Over five years, Operating Income peaked at -$568000.0 in Q1 2024 and troughed at -$14.8 million in Q4 2025.
• A 5-year average of -$2.5 million and a median of -$1.2 million in 2022 frame the typical range for Operating Income.
• Across the five-year window, Operating Income surged 58.9% in 2023 and sank 981.31% in 2025, its largest moves.
• Over 5 years, Operating Income stood at -$1.7 million in 2022, then surged by 58.9% to -$702000.0 in 2023, then slumped by 95.16% to -$1.4 million in 2024, then slumped by 981.31% to -$14.8 million in 2025, then soared by 63.05% to -$5.5 million in 2026.
• The last three Operating Income figures came in at -$5.5 million (Q2 2026), -$3.7 million (Q1 2026), and -$14.8 million (Q4 2025), per Business Quant data.